
April 16, 2019 Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma

April 15, 2019 Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma

April 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

April 12, 2019 Medical Communications, Research and Development Cancer, MSD, keytruda, lung cancer, non-small cell lung cancer, pharma

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

April 11, 2019 Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue

April 11, 2019 Research and Development Air pollution, NO2, Traffic, asthma, emissions, pollution, public health

April 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma

April 11, 2019 Research and Development Cancer, crispr, drug development, genes, genetics, oncology

April 10, 2019 Research and Development, Sales and Marketing Amgen, Evenity, FDA, UCB Pharma, osteoporosis, pharma

April 10, 2019 Research and Development Virginia, indivior, opioid crisis, opioids, suboxone

April 10, 2019 Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, breast cancer, lynparza, pharma